559 related articles for article (PubMed ID: 18941347)
1. New insights into uremic toxicity.
Raff AC; Meyer TW; Hostetter TH
Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):560-5. PubMed ID: 18941347
[TBL] [Abstract][Full Text] [Related]
2. Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.
Brettschneider F; Tölle M; von der Giet M; Passlick-Deetjen J; Steppan S; Peter M; Jankowski V; Krause A; Kühne S; Zidek W; Jankowski J
Artif Organs; 2013 Apr; 37(4):409-16. PubMed ID: 23330821
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
4. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
5. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.
Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J
Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752
[TBL] [Abstract][Full Text] [Related]
6. Uremic solutes from colon microbes.
Meyer TW; Hostetter TH
Kidney Int; 2012 May; 81(10):949-954. PubMed ID: 22318422
[TBL] [Abstract][Full Text] [Related]
7. Update of uremic toxin research by mass spectrometry.
Niwa T
Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
[TBL] [Abstract][Full Text] [Related]
8. Protein-Bound Uremic Toxins and Immunity.
Rocchetti MT; Cosola C; Ranieri E; Gesualdo L
Methods Mol Biol; 2021; 2325():215-227. PubMed ID: 34053061
[TBL] [Abstract][Full Text] [Related]
9. Protein-bound uremic solutes: the forgotten toxins.
Vanholder R; De Smet R; Lameire N
Kidney Int Suppl; 2001 Feb; 78():S266-70. PubMed ID: 11169024
[TBL] [Abstract][Full Text] [Related]
10. Protein-bound molecules: a large family with a bad character.
Sirich TL; Meyer TW; Gondouin B; Brunet P; Niwa T
Semin Nephrol; 2014 Mar; 34(2):106-17. PubMed ID: 24780467
[TBL] [Abstract][Full Text] [Related]
11. Albumin is the main plasma binding protein for indoxyl sulfate and p-cresyl sulfate.
Viaene L; Annaert P; de Loor H; Poesen R; Evenepoel P; Meijers B
Biopharm Drug Dispos; 2013 Apr; 34(3):165-75. PubMed ID: 23300093
[TBL] [Abstract][Full Text] [Related]
12. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
13. Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
Liabeuf S; Villain C; Massy ZA
Clin Sci (Lond); 2016 Dec; 130(23):2209-2216. PubMed ID: 27799624
[TBL] [Abstract][Full Text] [Related]
14. Cardiorenal syndrome: role of protein-bound uremic toxins.
Lekawanvijit S; Krum H
J Ren Nutr; 2015 Mar; 25(2):149-54. PubMed ID: 25556308
[TBL] [Abstract][Full Text] [Related]
15. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
16. Effects of AST-120 on blood concentrations of protein-bound uremic toxins and biomarkers of cardiovascular risk in chronic dialysis patients.
Lee CT; Hsu CY; Tain YL; Ng HY; Cheng BC; Yang CC; Wu CH; Chiou TT; Lee YT; Liao SC
Blood Purif; 2014; 37(1):76-83. PubMed ID: 24576840
[TBL] [Abstract][Full Text] [Related]
17. p-cresol sulfate and indoxyl sulfate: some clouds are gathering in the uremic toxin sky.
Evenepoel P; Glorieux G; Meijers B
Kidney Int; 2017 Dec; 92(6):1323-1324. PubMed ID: 29153138
[TBL] [Abstract][Full Text] [Related]
18. [Molecular mechanisms for uremic toxin-induced oxidative tissue damage via a cardiovascular-renal connection].
Watanabe H
Yakugaku Zasshi; 2013; 133(8):889-95. PubMed ID: 23903229
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
20. New insight into the redox properties of uremic solute indoxyl sulfate as a pro- and anti-oxidant.
Miyamoto Y; Watanabe H; Otagiri M; Maruyama T
Ther Apher Dial; 2011 Apr; 15(2):129-31. PubMed ID: 21426502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
